"I think this is a revolutionary new product that can help us aid in the management of safety and wellness for our patients. In that, we can highlight and see whether any areas, dark areas, could potentially be cancerous."
Innovative assessment for skin cancer risk
Meet the Device that is Leading AI Skin Cancer Detection
The DermaSensor device is the only FDA cleared, automated solution for skin cancer detection. The non-invasive, AI-powered device improves the early detection of cancerous lesions.
81%
Reported increased confidence in evaluating skin lesions.*
52%
Reduction in missed cancer referrals*
99%
Of physicians reported the device providing at least one device benefit*
96%
Sensitivity in detecting common skin cancers*
*Supporting publications available in the Resource section
Featured In Recognized media channels
Clinically Validated in Real-World Practice
DermaSensor supports clinical confidence through AI-assisted skin cancer risk assessments.
45,304
Suspicious Lesions Scanned To Date
Trusted by Physicians Nationwide
Hear directly from primary care physicians and specialists who use DermaSensor in clinical practice. Learn how DermaSensor strengthens clinical performance and confidence when assessing the risk of skin cancer and melanoma while also improving patient communication.
"DermaSensor has been a fantastic addition to our practice. It’s not invasive in any way, shape, or form. This is a completely painless procedure that can help us identify concerning skin lesions."
“Integrating DermaSensor device was pretty easy because it’s a device that is easy to use and it takes only a couple of minutes to assess the risk of skin cancer.”
Innovative, Efficient Solutions for Your Clinic
DermaSensor is designed to integrate into routine patient visits without disrupting clinical workflow. It is used across a range of healthcare settings to support skin cancer risk assessment.
-
Well-Established in Healthcare Institutions
DermaSensor has been widely adopted across hundreds of healthcare institutions and various healthcare specialities, including Primary Care, Health Systems, Speciality Care and Value-Based Care practices.
-
Maximized Efficiency
Seamlessly integrate DermaSensor into your workflow to support skin cancer risk assessment with prompt results. Using DermaSensor is a simple, three-step process.
See the DermaSensor Device in Action
Request a Demo
-
Expert Reimbursement Guidance
DermaSensor offers expert reimbursement guidance and support services through our partnership with The Reimbursement Group (TRG).
- Certified coding support
- Help with navigating payer requirements
- Support with reimbursement pathways
-
Provider Hotline Service
Connect directly with a TRG reimbursement specialist for individualized assistance and clarity on payer requirements.
- Phone: (888) 298-8848
- Hours: Monday–Friday, 8:00 AM – 8:00 PM ET
- Email: reimbursement@dermasensor.com
-
Documentation Help
We provide you with guidance in the preparation of coverage and payment documentation for payers, both government and commercial.
- Coding guidance for claims
- Access to the latest resources to support coverage and payment
Peace of Mind for Patients
DermaSensor has been positively received by patients who were assessed using the device by their primary care physician.
5.0 Based on clinician feedback
A Patient’s Experience with Skin Lesion Assessment Using DermaSensor
How We Utilize AI for Skin Cancer Assessments
The DermaSensor device uses a combination of Elastic Scattering Spectroscopy (ESS) and artificial intelligence to promptly analyze suspicious skin lesions suggestive of cancer. This assists in the detection of the three most common skin cancers (melanoma, basil cell carcinoma and squamous cell carcinoma) and has been found to reduce missed skin cancers by 52%.
Explore our Communications, White Papers and Research
Delve further into the news, research and clinical evidence behind DermaSensor.
COMMUNICATIONS
Press Releases
Read about our latest company news, announcements and comms in our latest press releases.
White Papers
Publications
Browse through our latest publications, and learn about the most up-to-date findings in detecting skin cancer.
Research
Brochures & Clinical Evidence
Learn about the intricate details of DermaSensor through our brochures and clinical evidence.
DermaSensor Accessories & Bonus Features
Alongside your DermaSensor device, we also provide you with training tools for you and your employees, on-demand customer support and other supplementary features.
-
Accessories
DermaSensor device comes with a charging dock, power supply, and regional power adapter blades.
-
Physician Finder Service
Explore NowBoost your practice’s presence by helping patients searching for skin cancer evaluation discover you when you join the Physician Finder.
-
Patient Education Resource Center
Explore NowOur resource center is a user-friendly portal that delivers customizable patient education materials, tailored to suit the needs of your employees and patients.
-
-
On-Demand Customer Support & Publications Access
Learn MoreOur support team is here to help and assist you. You also get access to the latest publications.
-
-
Latest Software Updates
Explore NowNew software updates are sent to your device as soon as they are available.
-
Remote Device Monitoring
Explore NowThis feature monitors connectivity and utilization of your device.
General Questions
Browse our FAQs for insights on how we work, what you can expect, and how we ensure your project's success.
What is DermaSensor?
DermaSensor is a software-aided adjunctive diagnostic device for use by physicians on lesions
suspicious for skin cancer. The device uses elastic scattering spectroscopy (optical
spectroscopy) and a locked, validated artificial intelligence algorithm to evaluate skin lesions
suspicious for melanoma, basal cell carcinoma, and squamous cell carcinoma. The handheld
device delivers light beneath the lesion surface and analyzes the light reflectance patterns from
cellular and sub-cellular features – including nuclear size, chromatin condensation, cellular
architecture, and collagen organization – using a proprietary machine learning algorithm,
providing an immediate point-of-care result.
What is AI skin cancer detection?
AI skin cancer detection refers to the use of artificial intelligence technology to help evaluate the risk of suspicious skin lesions and identify patterns that may be associated with skin cancer. This provides objective data to support clinical evaluation alongside visual examination. DermaSensor is the first and only FDA Cleared device that uses AI-driven technology to assist physicians in evaluating lesions suggestive of the three common skin cancers.
How can AI improve skin cancer detection in primary care?
AI provides objective analysis of suspicious skin lesions, helping reduce variability relative to visual assessment alone. DermaSensor uses clinically-proven technology to support providers during skin cancer assessments improving clinical confidence in evaluating lesions that may require further care. DermaSensor’s AI algorithm is locked and validated through various prospective clinical studies.
How does DermaSensor fit into clinical workflow?
DermaSensor is designed to integrate into routine patient visits without disrupting clinical workflow. The device provides rapid, point-of-care results to assist physicians in evaluating suspicious lesions during standard appointments.
Is reimbursement available for using DermaSensor?
Reimbursement may be available depending on payer policies and documentation requirements. DermaSensor provides expert reimbursement guidance and support services to help providers navigate coverage and payment considerations.
80-0009.10
